SXI Life Sciences
6.905,90
PKT
+48,39
PKT
+0,71
%
Werbung
Analysen zu SXI Life Sciences-Werten
Datum | Rating | Analyst | |
---|---|---|---|
21.10.05 | Novartis buy | Jyske Bank | |
18.10.05 | Novartis buy | Merrill Lynch | |
18.10.05 | Novartis buy | SEB | |
18.10.05 | Novartis Neutral | Banc of America Sec. | |
21.10.05 | Novartis halten | National-Bank AG | |
19.10.05 | Novartis market perform | Piper Jaffray | |
19.10.05 | Novartis overweight | Prudential Financial | |
17.10.05 | Novartis kaufen | Helaba Trust | |
18.10.05 | Novartis buy | Jyske Bank | |
11.10.05 | Novartis Neutral | Oppenheimer | |
07.10.05 | Lonza kaufen | Berenberg Bank | |
07.10.05 | Novartis | DZ-Bank | |
07.10.05 | Novartis overweight | Morgan Stanley | |
11.10.05 | Novartis buy | Jyske Bank | |
06.10.05 | Novartis | Zürcher Kantonalbank | |
05.10.05 | Novartis neutral | Susquehanna Financial | |
04.10.05 | Novartis Neutral | Susquehanna Financial | |
03.10.05 | Novartis buy | Deutsche Bank | |
04.10.05 | Novartis market perform | Piper Jaffray | |
30.09.05 | Novartis | DZ-Bank | |
30.09.05 | Novartis overweight | Prudential Financial | |
30.09.05 | Novartis outperform | WestLB | |
23.09.05 | Novartis | DZ-Bank | |
27.09.05 | Novartis buy | Jyske Bank | |
23.09.05 | Novartis outperform | HypoVereinsbank | |
21.09.05 | Novartis neutral | Bank Sarasin & Cie | |
22.09.05 | Novartis kaufen | Helaba Trust | |
21.09.05 | Novartis akkumulieren | Independent Research | |
20.09.05 | Novartis akkumulieren | Independent Research | |
16.09.05 | Novartis | DZ-Bank | |
16.09.05 | Lonza overweight | JP Morgan | |
20.09.05 | Novartis buy | Jyske Bank | |
15.09.05 | Novartis halten | Wertpapier | |
09.09.05 | Novartis hold | Deutsche Bank | |
09.09.05 | Novartis buy | A.G. Edwards & Sons | |
08.09.05 | Novartis Buy | AG Edwards | |
05.09.05 | Novartis | Weberbank | |
02.09.05 | Novartis average | Caris & Company | |
02.09.05 | Novartis akkumulieren | Independent Research | |
05.09.05 | Novartis Average | Caris & Company |